心血管磁共振参数定量成像在慢性心肌炎患者风险分层中的应用
回顾性纳入2017年9月至2021年11月连续88例疑似慢性心肌炎并接受CMR检查的患者,按2018 Lake Louise标准采集图像,中位随访21个月后31/88(35%)发生结局事件。基于native T1、T2、ECV改变程度联合左室功能不全的模型预测结局AUC达0.80,基于改变范围联合左室功能不全的模型AUC为0.71。
要点
- 慢性心肌炎患者中,CMR参数定量(native T1、T2、ECV)改变程度联合左室功能不全的模型预测结局AUC为0.80。
- 基于参数改变范围联合左室功能不全的模型预测结局AUC为0.71,预测能力良好。
- 中位随访21个月,35%(31/88)的慢性心肌炎患者发生心律失常、心力衰竭、反复胸痛或ICD/PM植入等结局。
核心结论
- CMR参数定量指标反映心肌损伤严重程度,其定量分析可能改善慢性心肌炎患者的风险分层,但临床应用前尚需进一步前瞻性研究验证。
研究设计与样本
- 回顾性研究,连续纳入2017年9月至2021年11月疑似慢性心肌炎并接受CMR检查的患者88例(年龄43[32-52]岁,男性53/88,60%),按2018 Lake Louise标准采集CMR,随访收集慢性心力衰竭、反复慢性心肌炎性胸痛、ICD/PM植入、心律失常(Lown分级≥2级)等结局。
关键影像表现/征象
- 以native T1、T2和细胞外容积分数(ECV)改变的范围与程度评估心肌损伤,联合左室射血分数构建多变量二元逻辑回归模型预测结局。
- 基于参数改变程度联合左室功能不全的模型预测结局AUC为0.80,基于参数改变范围联合左室功能不全的模型AUC为0.71。
- 中位随访21(17-34)个月,31/88(35%)患者发生结局事件。
诊断标准与关键数值
- 基于CMR参数定量改变程度联合左室功能不全的模型预测结局AUC为0.80。
- 基于CMR参数定量改变范围联合左室功能不全的模型预测结局AUC为0.71。
- 模型AUC比较采用DeLong检验,其余参数差异采用卡方检验、Fisher精确检验或Mann-Whitney U检验。
临床应用与阅片要点
- 在慢性心肌炎患者CMR报告中,可描述native T1、T2、ECV改变的范围与程度,并注明其与左室功能不全联合可用于风险分层。
- 作者指出该定量分析可能改善慢性心肌炎患者的风险分层,但临床应用前尚需进一步前瞻性研究验证。
局限性
- 原文指出临床应用前尚需进一步前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Chronic myocardial inflammation is the substrate for arrhythmias and dilated cardiomyopathy onset, causing morbidity and mortality. Cardiovascular magnetic resonance (CMR) is the noninvasive gold standard for myocardial inflammation detection, due to the high sensitivity of the parametric mapping techniques. However, the potential prognostic capabilities of CMR mapping have not been studied in the setting of chronic myocarditis.
METHODS: This is a retrospective study on consecutive patients undergoing CMR with suspicion of chronic myocarditis from September 2017 to November 2021. CMR was acquired according to 2018 Lake Louise Criteria recommendations. The outcome (chronic heart failure, recurrent chronic myocarditic chest pain, ICD/PM implantation, arrhythmias [Lown class ≥ 2]) was collected at follow-up. The extent and degree of native T1, T2, and extracellular volume fraction alterations were used to create multivariate binary logistic regression models for outcome prediction, with or without left ventricle ejection fraction; their AUCs were compared with DeLong test. Differences between other parameters were assessed using Chi-square test, Fisher's exact test, or Mann-Whitney U-test.
RESULTS: The population included 88 patients (age 43 [32-52] yo), mostly male (53/88, 60%). After a median follow-up of 21 (17-34) months, 31/88 (35%) patients experienced the outcome. The model based on the extension of mapping alterations and LV dysfunction reached a good predictability (AUC 0.71). The model based on the intensity of mapping alterations and LV dysfunction had a very good performance (AUC 0.80).
CONCLUSION: The quantitative analysis of CMR mapping parameters indicative of myocardial damage severity may improve risk stratification in patients with chronic myocarditis.
CLINICAL RELEVANCE STATEMENT: The intensity of myocardial damage, assessed as the degree of native T1, T2, and ECV alteration, together with left ventricle dysfunction, improved patient risk stratification. Further prospective studies will be necessary for validation before clinical application.
KEY POINTS: Risk stratification of patients affected by chronic myocarditis is an unmet clinical need. Cardiovascular MRI (CMR) can role in risk stratification thanks to its multiparametric capabilities of tissue characterization. A model based on CMR parametric mapping and left ventricle ejection fraction can predict arrhythmia, heart failure, and recurrent symptoms.
引用
- Vignale D, Bruno E, Palmisano A, et al. Cardiovascular magnetic resonance parametric mapping in the risk stratification of patients affected by chronic myocarditis. Eur Radiol. 2024. PMID: 39075299. doi:10.1007/s00330-024-10978-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。